Clinical Trial Update: Pharmacokinetic Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy volunteers sponsored by Orion Corporation related to Parkinson's disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Not disclosed compound

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED